qubit fluorometric quantification kit Search Results


qubit hs dna kit  (Thermo Fisher)
99
Thermo Fisher qubit hs dna kit
Qubit Hs Dna Kit, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/qubit+fluorometric+quantification+kit/10__3390_slash_agronomy15112588-93-14-20?v=Thermo+Fisher
Average 99 stars, based on 1 article reviews
qubit hs dna kit - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier
cell metertm fluorimetric intracellular total ros activity assay kit  (AAT Bioquest)
90
AAT Bioquest cell metertm fluorimetric intracellular total ros activity assay kit
Combination treatment with gefitinib and TRQ significantly increased <t>ROS</t> levels and cell redox ratio in NSCLC models. (A, B) Representative confocal image of mitochondrial superoxide (green, scale bars, 500 μm) and <t>intracellular</t> ROS (red, scale bars, 500 μm) in 2D cell lines after treated with gefitinib (2.5 μM), TRQ (0.6%) alone or together. (C, D) Representative confocal image of mitochondrial superoxide (green, scale bars, 50 μm) and intracellular ROS (yellow, scale bars, 50 μm) in 3D cell spheres after treated with gefitinib (20 μM), TRQ (0.8%) alone or together. (E, F) Representative morphology image and composite image in cell spheres after treated with gefitinib (20 μM), TRQ (0.8%) alone or together (scale bars, 50 μm). The higher the value was, the lower the cell redox ratio (FAD/[NADH+FAD]) was. The results are represented as mean ± SD. * P < 0.05 versus the control group, # P < 0.05 versus the gefitinib alone group, ** P or ## P < 0.01, *** P or ### P < 0.001. Ctrl, the control group; TRQ, Tanreqing injection; Gefi, gefitinib; PC-9-PIK3CA-M, PC-9-PIK3CA-mutation.
Cell Metertm Fluorimetric Intracellular Total Ros Activity Assay Kit, supplied by AAT Bioquest, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/qubit+fluorometric+quantification+kit/pmc11212081-85-10-20?v=AAT+Bioquest
Average 90 stars, based on 1 article reviews
cell metertm fluorimetric intracellular total ros activity assay kit - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
amplite fluorimetric d-lactate dehydrogenase assay kit  (AAT Bioquest)
90
AAT Bioquest amplite fluorimetric d-lactate dehydrogenase assay kit
Combination treatment with gefitinib and TRQ significantly increased <t>ROS</t> levels and cell redox ratio in NSCLC models. (A, B) Representative confocal image of mitochondrial superoxide (green, scale bars, 500 μm) and <t>intracellular</t> ROS (red, scale bars, 500 μm) in 2D cell lines after treated with gefitinib (2.5 μM), TRQ (0.6%) alone or together. (C, D) Representative confocal image of mitochondrial superoxide (green, scale bars, 50 μm) and intracellular ROS (yellow, scale bars, 50 μm) in 3D cell spheres after treated with gefitinib (20 μM), TRQ (0.8%) alone or together. (E, F) Representative morphology image and composite image in cell spheres after treated with gefitinib (20 μM), TRQ (0.8%) alone or together (scale bars, 50 μm). The higher the value was, the lower the cell redox ratio (FAD/[NADH+FAD]) was. The results are represented as mean ± SD. * P < 0.05 versus the control group, # P < 0.05 versus the gefitinib alone group, ** P or ## P < 0.01, *** P or ### P < 0.001. Ctrl, the control group; TRQ, Tanreqing injection; Gefi, gefitinib; PC-9-PIK3CA-M, PC-9-PIK3CA-mutation.
Amplite Fluorimetric D Lactate Dehydrogenase Assay Kit, supplied by AAT Bioquest, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/qubit+fluorometric+quantification+kit/pm37681955-215-51-57?v=AAT+Bioquest
Average 90 stars, based on 1 article reviews
amplite fluorimetric d-lactate dehydrogenase assay kit - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
quant-it picogreen dsdna assay kit  (Promega)
90
Promega quant-it picogreen dsdna assay kit
Combination treatment with gefitinib and TRQ significantly increased <t>ROS</t> levels and cell redox ratio in NSCLC models. (A, B) Representative confocal image of mitochondrial superoxide (green, scale bars, 500 μm) and <t>intracellular</t> ROS (red, scale bars, 500 μm) in 2D cell lines after treated with gefitinib (2.5 μM), TRQ (0.6%) alone or together. (C, D) Representative confocal image of mitochondrial superoxide (green, scale bars, 50 μm) and intracellular ROS (yellow, scale bars, 50 μm) in 3D cell spheres after treated with gefitinib (20 μM), TRQ (0.8%) alone or together. (E, F) Representative morphology image and composite image in cell spheres after treated with gefitinib (20 μM), TRQ (0.8%) alone or together (scale bars, 50 μm). The higher the value was, the lower the cell redox ratio (FAD/[NADH+FAD]) was. The results are represented as mean ± SD. * P < 0.05 versus the control group, # P < 0.05 versus the gefitinib alone group, ** P or ## P < 0.01, *** P or ### P < 0.001. Ctrl, the control group; TRQ, Tanreqing injection; Gefi, gefitinib; PC-9-PIK3CA-M, PC-9-PIK3CA-mutation.
Quant It Picogreen Dsdna Assay Kit, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/qubit+fluorometric+quantification+kit/pmc10218745-148-20-25?v=Promega
Average 90 stars, based on 1 article reviews
quant-it picogreen dsdna assay kit - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
fluorimetric epiquiktm dnmt activity assay kit  (EpiGentek)
90
EpiGentek fluorimetric epiquiktm dnmt activity assay kit
Combination treatment with gefitinib and TRQ significantly increased <t>ROS</t> levels and cell redox ratio in NSCLC models. (A, B) Representative confocal image of mitochondrial superoxide (green, scale bars, 500 μm) and <t>intracellular</t> ROS (red, scale bars, 500 μm) in 2D cell lines after treated with gefitinib (2.5 μM), TRQ (0.6%) alone or together. (C, D) Representative confocal image of mitochondrial superoxide (green, scale bars, 50 μm) and intracellular ROS (yellow, scale bars, 50 μm) in 3D cell spheres after treated with gefitinib (20 μM), TRQ (0.8%) alone or together. (E, F) Representative morphology image and composite image in cell spheres after treated with gefitinib (20 μM), TRQ (0.8%) alone or together (scale bars, 50 μm). The higher the value was, the lower the cell redox ratio (FAD/[NADH+FAD]) was. The results are represented as mean ± SD. * P < 0.05 versus the control group, # P < 0.05 versus the gefitinib alone group, ** P or ## P < 0.01, *** P or ### P < 0.001. Ctrl, the control group; TRQ, Tanreqing injection; Gefi, gefitinib; PC-9-PIK3CA-M, PC-9-PIK3CA-mutation.
Fluorimetric Epiquiktm Dnmt Activity Assay Kit, supplied by EpiGentek, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/qubit+fluorometric+quantification+kit/pmc05966399-216-9-15?v=EpiGentek
Average 90 stars, based on 1 article reviews
fluorimetric epiquiktm dnmt activity assay kit - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
qubit 2 0 fluorometer  (Thermo Fisher)
99
Thermo Fisher qubit 2 0 fluorometer
Combination treatment with gefitinib and TRQ significantly increased <t>ROS</t> levels and cell redox ratio in NSCLC models. (A, B) Representative confocal image of mitochondrial superoxide (green, scale bars, 500 μm) and <t>intracellular</t> ROS (red, scale bars, 500 μm) in 2D cell lines after treated with gefitinib (2.5 μM), TRQ (0.6%) alone or together. (C, D) Representative confocal image of mitochondrial superoxide (green, scale bars, 50 μm) and intracellular ROS (yellow, scale bars, 50 μm) in 3D cell spheres after treated with gefitinib (20 μM), TRQ (0.8%) alone or together. (E, F) Representative morphology image and composite image in cell spheres after treated with gefitinib (20 μM), TRQ (0.8%) alone or together (scale bars, 50 μm). The higher the value was, the lower the cell redox ratio (FAD/[NADH+FAD]) was. The results are represented as mean ± SD. * P < 0.05 versus the control group, # P < 0.05 versus the gefitinib alone group, ** P or ## P < 0.01, *** P or ### P < 0.001. Ctrl, the control group; TRQ, Tanreqing injection; Gefi, gefitinib; PC-9-PIK3CA-M, PC-9-PIK3CA-mutation.
Qubit 2 0 Fluorometer, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/qubit+fluorometric+quantification+kit/pmc12314205-111-19-22?v=Thermo+Fisher
Average 99 stars, based on 1 article reviews
qubit 2 0 fluorometer - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier
qubit fluorometer  (Thermo Fisher)
99
Thermo Fisher qubit fluorometer
Combination treatment with gefitinib and TRQ significantly increased <t>ROS</t> levels and cell redox ratio in NSCLC models. (A, B) Representative confocal image of mitochondrial superoxide (green, scale bars, 500 μm) and <t>intracellular</t> ROS (red, scale bars, 500 μm) in 2D cell lines after treated with gefitinib (2.5 μM), TRQ (0.6%) alone or together. (C, D) Representative confocal image of mitochondrial superoxide (green, scale bars, 50 μm) and intracellular ROS (yellow, scale bars, 50 μm) in 3D cell spheres after treated with gefitinib (20 μM), TRQ (0.8%) alone or together. (E, F) Representative morphology image and composite image in cell spheres after treated with gefitinib (20 μM), TRQ (0.8%) alone or together (scale bars, 50 μm). The higher the value was, the lower the cell redox ratio (FAD/[NADH+FAD]) was. The results are represented as mean ± SD. * P < 0.05 versus the control group, # P < 0.05 versus the gefitinib alone group, ** P or ## P < 0.01, *** P or ### P < 0.001. Ctrl, the control group; TRQ, Tanreqing injection; Gefi, gefitinib; PC-9-PIK3CA-M, PC-9-PIK3CA-mutation.
Qubit Fluorometer, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/qubit+fluorometric+quantification+kit/pm39800692-303-18-20?v=Thermo+Fisher
Average 99 stars, based on 1 article reviews
qubit fluorometer - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier
accublue broad range dsdna quantification kit  (Biotium)
93
Biotium accublue broad range dsdna quantification kit
Combination treatment with gefitinib and TRQ significantly increased <t>ROS</t> levels and cell redox ratio in NSCLC models. (A, B) Representative confocal image of mitochondrial superoxide (green, scale bars, 500 μm) and <t>intracellular</t> ROS (red, scale bars, 500 μm) in 2D cell lines after treated with gefitinib (2.5 μM), TRQ (0.6%) alone or together. (C, D) Representative confocal image of mitochondrial superoxide (green, scale bars, 50 μm) and intracellular ROS (yellow, scale bars, 50 μm) in 3D cell spheres after treated with gefitinib (20 μM), TRQ (0.8%) alone or together. (E, F) Representative morphology image and composite image in cell spheres after treated with gefitinib (20 μM), TRQ (0.8%) alone or together (scale bars, 50 μm). The higher the value was, the lower the cell redox ratio (FAD/[NADH+FAD]) was. The results are represented as mean ± SD. * P < 0.05 versus the control group, # P < 0.05 versus the gefitinib alone group, ** P or ## P < 0.01, *** P or ### P < 0.001. Ctrl, the control group; TRQ, Tanreqing injection; Gefi, gefitinib; PC-9-PIK3CA-M, PC-9-PIK3CA-mutation.
Accublue Broad Range Dsdna Quantification Kit, supplied by Biotium, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/qubit+fluorometric+quantification+kit/pm24324616-75-13-19?v=Biotium
Average 93 stars, based on 1 article reviews
accublue broad range dsdna quantification kit - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier
protein assay kit  (Thermo Fisher)
99
Thermo Fisher protein assay kit
Combination treatment with gefitinib and TRQ significantly increased <t>ROS</t> levels and cell redox ratio in NSCLC models. (A, B) Representative confocal image of mitochondrial superoxide (green, scale bars, 500 μm) and <t>intracellular</t> ROS (red, scale bars, 500 μm) in 2D cell lines after treated with gefitinib (2.5 μM), TRQ (0.6%) alone or together. (C, D) Representative confocal image of mitochondrial superoxide (green, scale bars, 50 μm) and intracellular ROS (yellow, scale bars, 50 μm) in 3D cell spheres after treated with gefitinib (20 μM), TRQ (0.8%) alone or together. (E, F) Representative morphology image and composite image in cell spheres after treated with gefitinib (20 μM), TRQ (0.8%) alone or together (scale bars, 50 μm). The higher the value was, the lower the cell redox ratio (FAD/[NADH+FAD]) was. The results are represented as mean ± SD. * P < 0.05 versus the control group, # P < 0.05 versus the gefitinib alone group, ** P or ## P < 0.01, *** P or ### P < 0.001. Ctrl, the control group; TRQ, Tanreqing injection; Gefi, gefitinib; PC-9-PIK3CA-M, PC-9-PIK3CA-mutation.
Protein Assay Kit, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/qubit+fluorometric+quantification+kit/10__3390_slash_pr8101228-89-15-18?v=Thermo+Fisher
Average 99 stars, based on 1 article reviews
protein assay kit - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier
qubit© 2.0 fluorometer  (Introgen Inc)
90
Introgen Inc qubit© 2.0 fluorometer
Combination treatment with gefitinib and TRQ significantly increased <t>ROS</t> levels and cell redox ratio in NSCLC models. (A, B) Representative confocal image of mitochondrial superoxide (green, scale bars, 500 μm) and <t>intracellular</t> ROS (red, scale bars, 500 μm) in 2D cell lines after treated with gefitinib (2.5 μM), TRQ (0.6%) alone or together. (C, D) Representative confocal image of mitochondrial superoxide (green, scale bars, 50 μm) and intracellular ROS (yellow, scale bars, 50 μm) in 3D cell spheres after treated with gefitinib (20 μM), TRQ (0.8%) alone or together. (E, F) Representative morphology image and composite image in cell spheres after treated with gefitinib (20 μM), TRQ (0.8%) alone or together (scale bars, 50 μm). The higher the value was, the lower the cell redox ratio (FAD/[NADH+FAD]) was. The results are represented as mean ± SD. * P < 0.05 versus the control group, # P < 0.05 versus the gefitinib alone group, ** P or ## P < 0.01, *** P or ### P < 0.001. Ctrl, the control group; TRQ, Tanreqing injection; Gefi, gefitinib; PC-9-PIK3CA-M, PC-9-PIK3CA-mutation.
Qubit© 2.0 Fluorometer, supplied by Introgen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/qubit+fluorometric+quantification+kit/pmc03991330__mmc1-49-12-15?v=Introgen+Inc
Average 90 stars, based on 1 article reviews
qubit© 2.0 fluorometer - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
nextquant library quant kit  (New England Biolabs)
96
New England Biolabs nextquant library quant kit
Combination treatment with gefitinib and TRQ significantly increased <t>ROS</t> levels and cell redox ratio in NSCLC models. (A, B) Representative confocal image of mitochondrial superoxide (green, scale bars, 500 μm) and <t>intracellular</t> ROS (red, scale bars, 500 μm) in 2D cell lines after treated with gefitinib (2.5 μM), TRQ (0.6%) alone or together. (C, D) Representative confocal image of mitochondrial superoxide (green, scale bars, 50 μm) and intracellular ROS (yellow, scale bars, 50 μm) in 3D cell spheres after treated with gefitinib (20 μM), TRQ (0.8%) alone or together. (E, F) Representative morphology image and composite image in cell spheres after treated with gefitinib (20 μM), TRQ (0.8%) alone or together (scale bars, 50 μm). The higher the value was, the lower the cell redox ratio (FAD/[NADH+FAD]) was. The results are represented as mean ± SD. * P < 0.05 versus the control group, # P < 0.05 versus the gefitinib alone group, ** P or ## P < 0.01, *** P or ### P < 0.001. Ctrl, the control group; TRQ, Tanreqing injection; Gefi, gefitinib; PC-9-PIK3CA-M, PC-9-PIK3CA-mutation.
Nextquant Library Quant Kit, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/qubit+fluorometric+quantification+kit/bio_rxiv__2025__02__27__640600-350-12-11?v=New+England+Biolabs
Average 96 stars, based on 1 article reviews
nextquant library quant kit - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

Image Search Results


Combination treatment with gefitinib and TRQ significantly increased ROS levels and cell redox ratio in NSCLC models. (A, B) Representative confocal image of mitochondrial superoxide (green, scale bars, 500 μm) and intracellular ROS (red, scale bars, 500 μm) in 2D cell lines after treated with gefitinib (2.5 μM), TRQ (0.6%) alone or together. (C, D) Representative confocal image of mitochondrial superoxide (green, scale bars, 50 μm) and intracellular ROS (yellow, scale bars, 50 μm) in 3D cell spheres after treated with gefitinib (20 μM), TRQ (0.8%) alone or together. (E, F) Representative morphology image and composite image in cell spheres after treated with gefitinib (20 μM), TRQ (0.8%) alone or together (scale bars, 50 μm). The higher the value was, the lower the cell redox ratio (FAD/[NADH+FAD]) was. The results are represented as mean ± SD. * P < 0.05 versus the control group, # P < 0.05 versus the gefitinib alone group, ** P or ## P < 0.01, *** P or ### P < 0.001. Ctrl, the control group; TRQ, Tanreqing injection; Gefi, gefitinib; PC-9-PIK3CA-M, PC-9-PIK3CA-mutation.

Journal: Journal of Cancer

Article Title: Tanreqing injection inhibits stemness and enhances sensitivity of non-small cell lung cancer models to gefitinib through ROS/STAT3 signaling pathway

doi: 10.7150/jca.94438

Figure Lengend Snippet: Combination treatment with gefitinib and TRQ significantly increased ROS levels and cell redox ratio in NSCLC models. (A, B) Representative confocal image of mitochondrial superoxide (green, scale bars, 500 μm) and intracellular ROS (red, scale bars, 500 μm) in 2D cell lines after treated with gefitinib (2.5 μM), TRQ (0.6%) alone or together. (C, D) Representative confocal image of mitochondrial superoxide (green, scale bars, 50 μm) and intracellular ROS (yellow, scale bars, 50 μm) in 3D cell spheres after treated with gefitinib (20 μM), TRQ (0.8%) alone or together. (E, F) Representative morphology image and composite image in cell spheres after treated with gefitinib (20 μM), TRQ (0.8%) alone or together (scale bars, 50 μm). The higher the value was, the lower the cell redox ratio (FAD/[NADH+FAD]) was. The results are represented as mean ± SD. * P < 0.05 versus the control group, # P < 0.05 versus the gefitinib alone group, ** P or ## P < 0.01, *** P or ### P < 0.001. Ctrl, the control group; TRQ, Tanreqing injection; Gefi, gefitinib; PC-9-PIK3CA-M, PC-9-PIK3CA-mutation.

Article Snippet: Intracellular total ROS was quantified following the instructions of by Cell MeterTM Fluorimetric Intracellular Total ROS Activity Assay Kit (22902, AAT Bioquest, CA, USA).

Techniques: Control, Injection, Mutagenesis

Combination treatment with gefitinib and TRQ inhibits the tumor growth in PC-9-PIK3CA-M xenograft model. (A) Evolution of tumor volumes of PC-9-PIK3CA-M xenograft model during treatment. (B) Representative PC-9-PIK3CA-M xenograft mice and tumors surgically removed. (C, D) The mRNA expression of SOX2, ALDH1A1 was assayed by PCR and protein levels of SOX2, ALDH1A1, p-STAT3 in tumors was detected by western blotting. (E) The intracellular ROS levels and mitochondrial superoxide levels in tumors was assayed by flow cytometry. Data were shown as means ± SD ( n = 5). * P < 0.05 versus the control group, # P < 0.05 versus the gefitinib alone group, ** P or ## P < 0.01, *** P or ### P < 0.001. Ctrl, the control group; TRQ, Tanreqing injection; Gefi, gefitinib; SOX2, sex determining region Y-box 2; ALDH1A1, aldehyde dehydrogenase family 1 member A1.

Journal: Journal of Cancer

Article Title: Tanreqing injection inhibits stemness and enhances sensitivity of non-small cell lung cancer models to gefitinib through ROS/STAT3 signaling pathway

doi: 10.7150/jca.94438

Figure Lengend Snippet: Combination treatment with gefitinib and TRQ inhibits the tumor growth in PC-9-PIK3CA-M xenograft model. (A) Evolution of tumor volumes of PC-9-PIK3CA-M xenograft model during treatment. (B) Representative PC-9-PIK3CA-M xenograft mice and tumors surgically removed. (C, D) The mRNA expression of SOX2, ALDH1A1 was assayed by PCR and protein levels of SOX2, ALDH1A1, p-STAT3 in tumors was detected by western blotting. (E) The intracellular ROS levels and mitochondrial superoxide levels in tumors was assayed by flow cytometry. Data were shown as means ± SD ( n = 5). * P < 0.05 versus the control group, # P < 0.05 versus the gefitinib alone group, ** P or ## P < 0.01, *** P or ### P < 0.001. Ctrl, the control group; TRQ, Tanreqing injection; Gefi, gefitinib; SOX2, sex determining region Y-box 2; ALDH1A1, aldehyde dehydrogenase family 1 member A1.

Article Snippet: Intracellular total ROS was quantified following the instructions of by Cell MeterTM Fluorimetric Intracellular Total ROS Activity Assay Kit (22902, AAT Bioquest, CA, USA).

Techniques: Expressing, Western Blot, Flow Cytometry, Control, Injection

Combination treatment with gefitinib and TRQ inhibits the organoids growth. (A) Seven organoids were treated with TRQ or gefitinib or their combination for 72 h, CellTiter-Glo® 3D Cell Viability Assay was performed to detect the cell viability ( n = 7). (B) The Q value method was used to assess the combined effect in seven organoids. The Q values were calculated from the average inhibition rate of each group. (C) The mRNA expression of SOX2 in organoids was assayed by PCR ( n = 3). (D) Representative morphology image and composite image in organoids (scale bars, 50 μm) ( n = 4). (E) Representative image of intracellular ROS (red, scale bars, 100 μm) and mitochondrial superoxide (green, scale bars, 100 μm) in organoids ( n = 3). The results were represented as mean ± SD. * P < 0.05 versus the control group, # P < 0.05 versus the gefitinib alone group, ** P or ## P < 0.01, *** P or ### P < 0.001. Ctrl, the control group; TRQ, Tanreqing injection; Gefi, gefitinib; SOX2, sex determining region Y-box 2.

Journal: Journal of Cancer

Article Title: Tanreqing injection inhibits stemness and enhances sensitivity of non-small cell lung cancer models to gefitinib through ROS/STAT3 signaling pathway

doi: 10.7150/jca.94438

Figure Lengend Snippet: Combination treatment with gefitinib and TRQ inhibits the organoids growth. (A) Seven organoids were treated with TRQ or gefitinib or their combination for 72 h, CellTiter-Glo® 3D Cell Viability Assay was performed to detect the cell viability ( n = 7). (B) The Q value method was used to assess the combined effect in seven organoids. The Q values were calculated from the average inhibition rate of each group. (C) The mRNA expression of SOX2 in organoids was assayed by PCR ( n = 3). (D) Representative morphology image and composite image in organoids (scale bars, 50 μm) ( n = 4). (E) Representative image of intracellular ROS (red, scale bars, 100 μm) and mitochondrial superoxide (green, scale bars, 100 μm) in organoids ( n = 3). The results were represented as mean ± SD. * P < 0.05 versus the control group, # P < 0.05 versus the gefitinib alone group, ** P or ## P < 0.01, *** P or ### P < 0.001. Ctrl, the control group; TRQ, Tanreqing injection; Gefi, gefitinib; SOX2, sex determining region Y-box 2.

Article Snippet: Intracellular total ROS was quantified following the instructions of by Cell MeterTM Fluorimetric Intracellular Total ROS Activity Assay Kit (22902, AAT Bioquest, CA, USA).

Techniques: Viability Assay, Inhibition, Expressing, Control, Injection